Trends in outcome and costs of coronary intervention in the 1990s

被引:33
作者
Weintraub, WS [1 ]
Mahoney, EM [1 ]
Ghazzal, ZMB [1 ]
King, SB [1 ]
Culler, SD [1 ]
Morris, DC [1 ]
Douglas, JS [1 ]
机构
[1] Emory Univ, Sch Publ Hlth, Sch Med, Div Cardiol, Atlanta, GA 30329 USA
关键词
D O I
10.1016/S0002-9149(01)01726-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our objective was to examine trends in outcome and cost of percutaneous coronary intervention (PCI) between 1990 and 1999. PCI has become the most common form of myocardial revascularization in recent years, rivaling the more established coronary artery, bypass surgery. There has been increasing interest in improving outcome of PCI while also seeking to minimize cost. A total of 21,755 patients undergoing PCI were evaluated. Clinical data were gathered from the Emory Cardiovascular Database and financial data from the UB92 formulation of the hospital bill. Charges were reduced to cost using departmental cost-to-charge ratios. Costs were inflated to 1999 dollars using medical care inflation rates. Mortality varied without a significant trend from 0.63% to 0.44% (p = 0.64). The Q-wave myocardial infarction rate decreased from 0.68% to 0.40% (p = 0.0003). Emergent coronary surgery decreased from 3.50% to 1.25% (p <0.0001). Mean hospital inflation-adjusted cost decreased from $10,478 to $8,367 (p <0.0001). Length of stay after the procedure decreased from 2.8 to 1.8 days (p <0.0001). Outcome of PCI continues to improve, with a decrease in coronary surgery and Q-wave myocardial infarction but with no significant change in mortality. This was accomplished while also decreasing costs and length of stay. Whether these favorable trends will continue remains to be seen. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 27 条
[11]   PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY IN NEW-YORK-STATE - RISK-FACTORS AND OUTCOMES [J].
HANNAN, EL ;
ARANI, DT ;
JOHNSON, LW ;
KEMP, HG ;
LUKACIK, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (21) :3092-3097
[12]  
Hanrath P, 1997, CIRCULATION, V96, P1445
[13]  
HARRELL FE, FUNCTIONS BIOSTATIST
[14]   Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery [J].
Hlatky, MA ;
Rogers, WJ ;
Johnstone, I ;
Boothroyd, D ;
Brooks, MM ;
Pitt, B ;
Reeder, G ;
Ryan, T ;
Smith, H ;
Whitlow, P ;
Wiens, R ;
Mark, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (02) :92-99
[15]   A RANDOMIZED TRIAL COMPARING CORONARY ANGIOPLASTY WITH CORONARY-BYPASS SURGERY [J].
KING, SB ;
LEMBO, NJ ;
WEINTRAUB, WS ;
KOSINSKI, AS ;
BARNHART, HX ;
KUTNER, NH ;
ALAZRAKI, NP ;
GUYTON, RA ;
ZHAO, XQ ;
ROUBIN, GS ;
CRAVER, JM ;
DOUGLAS, JS ;
JONES, EL ;
MORRIS, DC ;
DEPUEY, EG ;
BATTEY, LL ;
KRAWCZYNSKA, EG ;
KLEIN, JL ;
LIBERMAN, HA ;
MAULDIN, P ;
YEEPETERSON, J ;
FRERICHS, FA ;
MAYS, RR ;
MEAD, SI ;
CARLIN, SF ;
CASEY, M ;
MCFARLAND, K ;
MILLER, SJ ;
PEEBLES, BU ;
SCOTT, J ;
SUTOR, CE ;
KUTNER, MH ;
GRIFFIN, PJ ;
LYNN, MJ ;
SANDERS, AG ;
HALL, EC ;
JAMISON, P ;
MELLON, B ;
THOMAS, RG .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (16) :1044-1050
[16]   Indications, practice, and procedural outcomes of percutaneous transluminal coronary angioplasty in northern New England in the early 1990s [J].
Malenka, DJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (03) :260-265
[17]  
MANTEL N, 1963, J AM STAT ASSOC, V58, P690
[18]   Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty [J].
Mark, DB ;
Talley, JD ;
Topol, EJ ;
Bowman, L ;
Lam, LC ;
Anderson, KM ;
Jollis, JG ;
Cleman, MW ;
Lee, KL ;
Aversano, T ;
Untereker, WJ ;
DavidsonRay, L ;
Califf, RM .
CIRCULATION, 1996, 94 (04) :629-635
[19]   A COMPARISON OF ANGIOPLASTY WITH MEDICAL THERAPY IN THE TREATMENT OF SINGLE-VESSEL CORONARY-ARTERY DISEASE [J].
PARISI, AF ;
FOLLAND, ED ;
HARTIGAN, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (01) :10-16
[20]   CORONARY ANGIOPLASTY - STATEWIDE EXPERIENCE IN CALIFORNIA [J].
RITCHIE, JL ;
PHILLIPS, KA ;
LUFT, HS .
CIRCULATION, 1993, 88 (06) :2735-2743